By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PR Pharmaceuticals, Inc. 

P.O. Box 2126
1716 Heath Parkway
Fort Collins  Colorado  80522-2126  U.S.A.
Phone: 970-484-5560 Fax: 970-482-6184



Company News
AntriaBio Acquires Assets of PR Pharmaceuticals, Inc. and Announces Intent to Merge With a Public Company 1/7/2013 10:24:42 AM
SurModics Inc. (SRDX) Acquires Drug Delivery Assets of PR Pharmaceuticals, Inc. 11/5/2008 6:55:50 AM
Jerini Ophthalmic and PR Pharmaceuticals, Inc. Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases 4/10/2008 2:54:41 PM
PR Pharmaceuticals, Inc. Announces Initiation Of A Phase I Study Of A New Potential Treatment For Pulmonary Arterial Hypertension 3/28/2006 11:02:40 AM
PR Pharmaceuticals, Inc. Release: New Patent Issued To The University of Pittsburgh For 2-Methoxyestradiol 3/16/2006 11:10:16 AM
PR Pharmaceuticals, Inc. Announces Collaboration With OSI Pharmaceuticals, Inc. (OSIP) To Develop Sustained Release Formulation Of Macugen(R) 1/11/2006 10:24:10 AM
PR Pharmaceuticals, Inc. Files IND For Pulmonary Hypertension 12/20/2005 10:36:52 AM
PR Pharmaceuticals, Inc.'s PulmoLAR(TM) Granted Orphan Drug Status10/19/2005 5:10:15 PM